Digital mammography: what do we and what don’t we know?

被引:0
|
作者
Ulrich Bick
Felix Diekmann
机构
[1] Charité-Universitätsmedizin Berlin,Department of Radiology
来源
European Radiology | 2007年 / 17卷
关键词
Digital mammography; Breast cancer screening; Image processing; Workflow; Quality assurance;
D O I
暂无
中图分类号
学科分类号
摘要
High-quality full-field digital mammography has been available now for several years and is increasingly used for both diagnostic and screening mammography. A number of different detector technologies exist, which all have their specific advantages and disadvantages. Diagnostic accuracy of digital mammography has been shown to be at least equivalent to film-screen mammography in a general screening population. Digital mammography is superior to screen-film mammography in younger women with dense breasts due to its ability to selectively optimize contrast in areas of dense parenchyma. This advantage is especially important in women with a genetic predisposition for breast cancer, where intensified early detection programs may have to start from 25 to 30 years of age. Tailored image processing and computer-aided diagnosis hold the potential to further improve the early detection of breast cancer. However, at present no consensus exists among radiologists on which processing is optimal for digital mammograms. Image processing may also vary significantly among vendors with so far limited interoperability. This review aims to summarize the available information regarding the impact of digital mammography on workflow and breast cancer diagnosis.
引用
收藏
页码:1931 / 1942
页数:11
相关论文
共 50 条
  • [31] Thymic neuroendocrine neoplasms-what we know, what we don't know, and what to do about it
    Lang, Matthias
    Pausch, Thomas M.
    Anamaterou, Chrysanthi
    [J]. TRANSLATIONAL CANCER RESEARCH, 2023, 12 (01) : 1 - 3
  • [32] Metabolic syndrome - What we know and what we don't know
    Ritz, Eberhard
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1619 - 1623
  • [33] "Tau oligomers," what we know and what we don't know
    Sahara, Naruhiko
    Avila, Jesus
    [J]. FRONTIERS IN NEUROLOGY, 2014, 5
  • [34] Fulleride superconductors: What we know and what we don't know
    Fischer, JE
    [J]. CHEMICAL PHYSICS OF FULLERENES 10 (AND 5) YEARS LATER: THE FAR-REACHING IMPACT OF THE DISCOVERY OF C60, 1996, 316 : 359 - 382
  • [35] Corporate governance: what we know and what we don't know
    Elston, Julie
    [J]. JOURNAL OF INDUSTRIAL AND BUSINESS ECONOMICS, 2019, 46 (02): : 147 - 156
  • [36] What we know and what we don't know about the universe
    Gleiser, M
    [J]. INTERNATIONAL JOURNAL OF MODERN PHYSICS D, 2004, 13 (07): : 1381 - 1388
  • [37] Dialyzer reuse: What we know and what we don't know
    Kaplan, AA
    [J]. SEMINARS IN DIALYSIS, 2000, 13 (05) : 271 - 274
  • [38] Corporate governance: what we know and what we don’t know
    Julie Elston
    [J]. Journal of Industrial and Business Economics, 2019, 46 : 147 - 156
  • [39] Business and IT Alignment: What we know and what we don't know
    Silvius, A. J. Gilbert
    [J]. 2009 INTERNATIONAL CONFERENCE ON INFORMATION MANAGEMENT AND ENGINEERING, PROCEEDINGS, 2009, : 558 - 563
  • [40] Destination competitiveness: what we know, what we know but shouldn't and what we don't know but should
    Abreu-Novais, Margarida
    Ruhanen, Lisa
    Arcodia, Charles
    [J]. CURRENT ISSUES IN TOURISM, 2016, 19 (06) : 492 - 512